Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)

被引:0
|
作者
Yan Li
Hui Shi
Zhenjun Zhao
Minghui Xu
机构
[1] Yantai University,College of Life Sciences
[2] Sun Yat-sen University,School of Life Sciences
来源
BMC Urology | / 22卷
关键词
Differentially expressed genes (DEGs); Castration-resistant prostate cancer (CRPC); Cell cycle; Cell proliferation; Prostate gland development;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Identification of castration-dependent and -independent driver genes and pathways in castration-resistant prostate cancer (CRPC)
    Li, Yan
    Shi, Hui
    Zhao, Zhenjun
    Xu, Minghui
    BMC UROLOGY, 2022, 22 (01)
  • [2] Castration-resistant prostate cancer (CRPC)
    Loidl, W.
    Luger, F.
    Roosen, A.
    UROLOGE, 2014, 53 (03): : 391 - 399
  • [3] Mechanisms of resistance in castration-resistant prostate cancer (CRPC)
    Chandrasekar, Thenappan
    Yang, Joy C.
    Gao, Allen C.
    Evans, Christopher P.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2015, 4 (03) : 365 - 380
  • [4] Role of Immunotherapy in Castration-Resistant Prostate Cancer (CRPC)
    Suarez, Cristina
    Morales-Barrera, Rafael
    Ramos, Victor
    Nunez, Isaac
    Valverde, Claudia
    Planas, Jacques
    Morote, Juan
    Maldonado, Xavier
    Carles, Joan
    BJU INTERNATIONAL, 2014, 113 (03) : 367 - 375
  • [5] Castration-resistant prostate cancer (CRPC) [Kastrationsrefraktäres prostatakarzinom (CRPC)]
    Loidl W.
    Luger F.
    Roosen A.
    Der Urologe, 2014, 53 (3): : 391 - 401
  • [6] Identification of Docetaxel Resistance Genes in Castration-Resistant Prostate Cancer
    Marin-Aguilera, Mercedes
    Codony-Servat, Jordi
    Kalko, Susana G.
    Fernandez, Pedro L.
    Bermudo, Raquel
    Buxo, Elvira
    Jose Ribal, Maria
    Gascon, Pedro
    Mellado, Begona
    MOLECULAR CANCER THERAPEUTICS, 2012, 11 (02) : 329 - 339
  • [7] DISEASE BURDEN OF CASTRATION-RESISTANT PROSTATE CANCER (CRPC) IN CHINA
    Ma, F. F.
    Liu, Q.
    Wang, J.
    Zhang, X. J.
    Yu, F.
    VALUE IN HEALTH, 2020, 23 : S451 - S452
  • [8] CASTRATION-RESISTANT PROSTATE CANCER (CRPC): A UK EPIDEMIOLOGY STUDY
    Morgan, C.
    McEwan, P.
    Chamberlain, G.
    Cabrera, C.
    Parry, D.
    VALUE IN HEALTH, 2010, 13 (03) : A26 - A26
  • [9] Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)
    Lee, Daniel J.
    Cha, Eugene K.
    Dubin, Justin M.
    Beltran, Himisha
    Chromecki, Thomas F.
    Fajkovic, Harun
    Scherr, Douglas S.
    Tagawa, Scott T.
    Shariat, Shahrokh F.
    BJU INTERNATIONAL, 2012, 109 (07) : 968 - +
  • [10] Retreatment with docetaxel in metastatic castration-resistant prostate cancer (CRPC).
    Gernone, A.
    Pagliarulo, A.
    Pagliarulo, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)